Presented to the International Low Vision Support Group by Dan Roberts July 2013 [Opening: montage of screen shots and audio of disclaimers from drug commercials] Pretty scary, isn’t it? Kind of like telling us we’re going to feel better or die trying. These commercials, which show peaceful scenes of happy people while a disembodied voice [Read More]
Author: droberts
Betadine and Eye Pain
Betadine (povidone-iodine 5%) has become the standard of care for cleansing the eye during anti-VEGF injection procedures. Though the incidence of sensitivity to povidone-iodine (PVPI) is infrequent, some patients are reporting severe and prolonged burning of the conjunctiva.1, 2, 3 Even though the complaints are relatively few, a solution needs to be found to this [Read More]
Floaters and Flashers
Floaters Floaters are actually cellular debris within the vitreous, the jelly-like fluid that fills the inside of the eye. They may be seen as strings, streaks, clouds, bugs, dots, dust, or spider webs. These objects appear to be in front of the eye, but they are really floating in this fluid, and at the same [Read More]
New Anti-PDGF Aptamer Now in Trials
by Dan Roberts February 15, 2008 Ophthotech has begun the first phase of a clinical trial of E10030, an anti-platelet derived growth factor aptamer being developed for treating wet AMD. The trial will evaluate the safety and tolerability of E10030 in combination with an antiangiogenic drug. The hope is that the combination will result in [Read More]
Summary of Research and Developments in Macular Degeneration, 2012-2013
by Dan Roberts June 2013 INTRODUCTION This is a summary of reports about significant research and development in the field of macular degeneration and related diseases presented since June 2012 and May 2013. I will briefly describe the conclusions of 77 studies that have been presented in the areas of therapy, prevention, technology, nutrition and [Read More]